© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
February 27, 2021
A discussion on continued research into the first regulated treatment for pediatric peanut allergy.
Treatment showed a similar effect on patients with and without baseline asthma.
February 26, 2021
The indication was granted on the basis of data showing an 84% survival rate among a young pediatric population that face fatal disease severity.
February 25, 2021
The approval is based on results from the ENVISION I Phase 3 study, which showed biologic use linked to clinical remission and maintenance in patients.
February 23, 2021
Children and adolescents with direct or indirect exposure to tobacco had higher odds of having elevated blood pressure.
February 22, 2021
Up to 84% of younger patients note a positive experience with holistic therapeutic approaches to treating sickle cell-related pain.
February 16, 2021
The investigators found the primary efficacy endpoints occurred in 20 evaluable patients (87%).
Phase 3 COMET findings show the Sanofi Genzyme product delivered significantly improved efficacy and safety for the rare autosomal disorder.
February 15, 2021
In a joint interview, 2 pediatric cardiologists discuss topics related to remote technologies and cardiological monitoring among pediatric populations.
February 14, 2021
Two pediatric cardiologists stress that recognizing symptoms of MIS-C is essential for primary care providers.